2000
DOI: 10.1211/0022357001774787
|View full text |Cite
|
Sign up to set email alerts
|

Chronopharmaceutical Drug Delivery from a Pulsatile Capsule Device based on Programmable Erosion

Abstract: We report the development of a chronopharmaceutical capsule drug delivery system capable of releasing drug after pre-determined time delays. The drug formulation is sealed inside the insoluble capsule body by an erodible tablet (ET). The release time is determined by ET erosion rate and increases as the content of an insoluble excipient (dibasic calcium phosphate) and of gel-forming excipient (hydroxypropylmethylcellulose; HPMC) increases. The time-delayed release of a model drug (propranolol HCI) was investig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
24
0

Year Published

2004
2004
2016
2016

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(24 citation statements)
references
References 22 publications
0
24
0
Order By: Relevance
“…[5][6][7] In order to achieve the chronopharmaceutical design for these time-controlled release preparations, currently formulation design to control the lag time is prior to the substantial release of drug. [8][9] Recently, a TIMERx technology with an erosion mechanism was developed to achieve the chronotherapeutic delivery system. 10 Ethylcellulose (EC) is a well-known water-insoluble polymer that has long been used as a rate-controlling membrane in medication dosage forms to regulate drug release.…”
Section: Introductionmentioning
confidence: 99%
“…[5][6][7] In order to achieve the chronopharmaceutical design for these time-controlled release preparations, currently formulation design to control the lag time is prior to the substantial release of drug. [8][9] Recently, a TIMERx technology with an erosion mechanism was developed to achieve the chronotherapeutic delivery system. 10 Ethylcellulose (EC) is a well-known water-insoluble polymer that has long been used as a rate-controlling membrane in medication dosage forms to regulate drug release.…”
Section: Introductionmentioning
confidence: 99%
“…These systems normally consist of a core and a coating. The core is coated with different barriers by film or compression, and the coating can prevent drug quick-release from the core until the shell is completely swollen or eroded by liquid substance in vivo (Ross et al, 2000;Li and Zhu, 2004). These new pharmaceutical preparations can exhibit drug release constantly at a steady rate, the slow and sustained…”
Section: Introductionmentioning
confidence: 99%
“…4,5 Capsule-based pulsatile release systems have also been developed which are coated with a water-impermeable or semipermeable membrane containing a hydrogel polymer plug which swells with time after coming into contact with gastrointestinal fluid, and exerts an internal pressure leading to release of drug after rupture of the membrane. [6][7][8] Pulsatile tablet formulations are manufactured with a rapid-release core (reservoir) encased in a barrier layer formed by rupturable press coating or liquid coating of erodible and swelling polymer. [9][10][11] Polymers like various grades of Eudragit ® or ethyl cellulose have been tested as film coating to achieve the desired lag time.…”
Section: Introductionmentioning
confidence: 99%